{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T10:05:27Z","timestamp":1785924327875,"version":"3.56.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejps.2024.106990","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T16:39:17Z","timestamp":1734021557000},"page":"106990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The evaluation of DNA-linked inhibitor antibody and AlphaScreen assays for high-throughput screening of compounds targeting the cap-binding domain in influenza a polymerase"],"prefix":"10.1016","volume":"205","author":[{"given":"Kate\u0159ina","family":"\u010cerm\u00e1kov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Gregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Kr\u00e1\u013e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Karlukova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e1clav","family":"Navr\u00e1til","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3bert","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Berenguer","family":"Albi\u00f1ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edt","family":"Bechynsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Majer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Konvalinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ale\u0161","family":"Machara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9476-3409","authenticated-orcid":false,"given":"Milan","family":"Ko\u017e\u00ed\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejps.2024.106990_bib0001","first-page":"9","article-title":"Tris-(Nitrilotriacetic Acid)-decorated polymer conjugates as tools for immobilization and visualization of his-tagged proteins","author":"Beranova","year":"2019","journal-title":"Catalysts"},{"issue":"9","key":"10.1016\/j.ejps.2024.106990_bib0002","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.bmcl.2015.03.013","article-title":"Isosteric replacements of the carboxylic acid of drug candidate VX-787: effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors","volume":"25","author":"Boyd","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.ejps.2024.106990_bib0003","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/AAC.04623-14","article-title":"Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit","volume":"59","author":"Byrn","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.ejps.2024.106990_bib0004","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.drudis.2022.02.024","article-title":"Approaches for discovery of small-molecular antivirals targeting to influenza A virus PB2 subunit","volume":"27","author":"Chen","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"15","key":"10.1016\/j.ejps.2024.106990_bib0005","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1021\/jm5007275","article-title":"Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2","volume":"57","author":"Clark","year":"2014","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejps.2024.106990_bib0006","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1021\/acsmedchemlett.6b00486","article-title":"Discovery of novel, orally bioavailable beta-amino acid azaindole inhibitors of influenza PB2","volume":"8","author":"Farmer","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.ejps.2024.106990_bib0007","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/jiy547","article-title":"Phase 2b study of pimodivir (JNJ-63623872) as Monotherapy or in combination with Oseltamivir for treatment of acute uncomplicated seasonal influenza A: TOPAZ trial","volume":"219","author":"Finberg","year":"2019","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.ejps.2024.106990_bib0008","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ejps.2024.106990_bib0009","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12551-020-00619-2","article-title":"Theory and applications of differential scanning fluorimetry in early-stage drug discovery","volume":"12","author":"Gao","year":"2020","journal-title":"Biophys. Rev."},{"issue":"4","key":"10.1016\/j.ejps.2024.106990_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26041007","article-title":"Structural and thermodynamic analysis of the resistance development to Pimodivir (VX-787), the clinical inhibitor of cap binding to PB2 subunit of influenza a polymerase","volume":"26","author":"Gregor","year":"2021","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.ejps.2024.106990_bib0011","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nsmb.1421","article-title":"The structural basis for cap binding by influenza virus polymerase subunit PB2","volume":"15","author":"Guilligay","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"5","key":"10.1016\/j.ejps.2024.106990_bib0012","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/AAC.40.5.1304","article-title":"Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors","volume":"40","author":"Hastings","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2024.106990_bib0013","article-title":"DNA-linked inhibitor antibody assay (DIANA) as a new method for screening influenza neuraminidase inhibitors","author":"Kozisek","year":"2018","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.ejps.2024.106990_bib0014","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.antiviral.2011.09.001","article-title":"In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections","volume":"92","author":"Kumaki","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ejps.2024.106990_bib0015","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.antiviral.2017.06.009","article-title":"Identification of influenza polymerase inhibitors targeting polymerase PB2 cap-binding domain through virtual screening","volume":"144","author":"Liu","year":"2017","journal-title":"Antiviral Res."},{"issue":"9","key":"10.1016\/j.ejps.2024.106990_bib0016","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1021\/acs.molpharmaceut.8b00531","article-title":"A small-molecule compound has anti-influenza a virus activity by acting as a ''PB2 inhibitor","volume":"15","author":"Liu","year":"2018","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2024.106990_bib0017","doi-asserted-by":"crossref","first-page":"9385","DOI":"10.1038\/s41598-017-09538-x","article-title":"Structural basis for therapeutic inhibition of influenza A polymerase PB2 subunit","volume":"7","author":"Ma","year":"2017","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.ejps.2024.106990_bib0018","doi-asserted-by":"crossref","first-page":"9680","DOI":"10.1021\/acs.jmedchem.9b01091","article-title":"Design, synthesis, and biological evaluation of novel indoles targeting the influenza PB2 cap binding region","volume":"62","author":"McGowan","year":"2019","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejps.2024.106990_bib0019","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/nar\/gkw853","article-title":"DNA-linked inhibitor antibody assay (DIANA) for sensitive and selective enzyme detection and inhibitor screening","volume":"45","author":"Navratil","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"21","key":"10.1016\/j.ejps.2024.106990_bib0020","doi-asserted-by":"crossref","first-page":"8915","DOI":"10.1021\/jm401369y","article-title":"New 7-methylguanine derivatives targeting the influenza polymerase PB2 cap-binding domain","volume":"56","author":"Pautus","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2024.106990_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105449","article-title":"Thermodynamic and structural characterization of an optimized peptide-based inhibitor of the influenza polymerase PA-PB1 subunit interaction","author":"Radilova","year":"2022","journal-title":"Antiviral Res."},{"issue":"8","key":"10.1016\/j.ejps.2024.106990_bib0022","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1089\/adt.2015.668","article-title":"An RNA hybridization assay for screening influenza A virus polymerase inhibitors using the entire ribonucleoprotein complex","volume":"13","author":"Roch","year":"2015","journal-title":"Assay Drug Dev. Technol."},{"issue":"1","key":"10.1016\/j.ejps.2024.106990_bib0023","doi-asserted-by":"crossref","first-page":"22820","DOI":"10.1038\/s41598-023-50158-5","article-title":"Limited high-throughput screening compatibility of the phenuivirus cap-binding domain","volume":"13","author":"Scherf","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ejps.2024.106990_bib0024","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1124\/jpet.106.111807","article-title":"Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel","volume":"319","author":"Shi","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.ejps.2024.106990_bib0025","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1128\/AAC.32.6.906","article-title":"Comparative activities of several nucleoside analogs against influenza A, B, and C viruses in vitro","volume":"32","author":"Shigeta","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.ejps.2024.106990_bib0026","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/med.21401","article-title":"The influenza virus polymerase complex: an update on its structure, functions, and significance for antiviral drug design","volume":"36","author":"Stevaert","year":"2016","journal-title":"Med. Res. Rev."},{"issue":"45","key":"10.1016\/j.ejps.2024.106990_bib0027","doi-asserted-by":"crossref","first-page":"19151","DOI":"10.1073\/pnas.1013592107","article-title":"High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity","volume":"107","author":"Su","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2024.106990_bib0028","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbrc.2023.08.027","article-title":"Discovery of a potent inhibitor targeting the cap-binding domain of the PB2 subunit of influenza RNA-dependent RNA polymerase","volume":"678","author":"Sun","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.ejps.2024.106990_bib0029","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038687","article-title":"Influenza polymerase inhibitors: mechanisms of action and resistance","volume":"11","author":"Takashita","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"8","key":"10.1016\/j.ejps.2024.106990_bib0030","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrmicro.2016.87","article-title":"Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis","volume":"14","author":"Te Velthuis","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"issue":"12","key":"10.1016\/j.ejps.2024.106990_bib0031","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1128\/AAC.38.12.2827","article-title":"Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds","volume":"38","author":"Tomassini","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.ejps.2024.106990_bib0032","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3851\/IMP3212","article-title":"Pimodivir treatment in adult volunteers experimentally inoculated with live influenza virus: a Phase IIa, randomized, double-blind, placebo-controlled study","volume":"23","author":"Trevejo","year":"2018","journal-title":"Antivir. Ther."},{"issue":"9","key":"10.1016\/j.ejps.2024.106990_bib0033","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1177\/2472555220918836","article-title":"Identification of novel carbonic anhydrase IX inhibitors using high-throughput screening of pooled compound libraries by DNA-linked inhibitor antibody assay (DIANA)","volume":"25","author":"Tykvart","year":"2020","journal-title":"SLAS Discov."},{"issue":"1","key":"10.1016\/j.ejps.2024.106990_bib0034","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1074\/jbc.M115.693051","article-title":"Molecular basis of mRNA cap recognition by influenza B polymerase PB2 subunit","volume":"291","author":"Xie","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2024.106990_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116515","article-title":"Identification of novel influenza polymerase PB2 inhibitors using virtual screening approach and molecular dynamics simulation analysis of active compounds","volume":"52","author":"Xu","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"13","key":"10.1016\/j.ejps.2024.106990_bib0036","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.bmcl.2019.04.042","article-title":"Discovery of 5-(5-fluoro-1H-pyrrolo [2,3-b] pyridin-3-yl)pyrazin-2(1H)-one derivatives as new potent PB2 inhibitors","volume":"29","author":"Yang","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2024.106990_bib0037","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-4939-3673-1_5","article-title":"AlphaScreen-based assays: ultra-high-throughput screening for small-molecule inhibitors of challenging enzymes and protein-protein interactions","volume":"1439","author":"Yasgar","year":"2016","journal-title":"Methods Mol. Biol."},{"issue":"9","key":"10.1016\/j.ejps.2024.106990_bib0038","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/jac\/dkw194","article-title":"A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication","volume":"71","author":"Yuan","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.ejps.2024.106990_bib0039","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen."},{"issue":"13","key":"10.1016\/j.ejps.2024.106990_bib0040","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.bmc.2019.05.024","article-title":"Investigation of flexibility of neuraminidase 150-loop using tamiflu derivatives in influenza A viruses H1N1 and H5N1","volume":"27","author":"Zima","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2024.106990_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112754","article-title":"Unraveling the anti-influenza effect of flavonoids: experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors","volume":"208","author":"Zima","year":"2020","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724003038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724003038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T15:20:30Z","timestamp":1736608830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724003038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":41,"alternative-id":["S0928098724003038"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106990","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evaluation of DNA-linked inhibitor antibody and AlphaScreen assays for high-throughput screening of compounds targeting the cap-binding domain in influenza a polymerase","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106990"}}